Clopidogrel (Clopicard 75mg) is an anti-platelet agent, that is, a drug that inhibits the ability of platelets to clump together as part of a blood clot. Clopidogrel (Clopicard 75mg) is prescribed ...

A single lot of 75-mg clopidogrel tablets that was distributed nationwide is being recalled by the manufacturer due to mislabeling. International Laboratories, LLC voluntarily initiated the recall ...

Clopidogrel (Noklot (300 mg)) is an anti-platelet agent, that is, a drug that inhibits the ability of platelets to clump together as part of a blood clot. Clopidogrel (Noklot (300 mg)) is prescribed ...

Aurobindo Pharma has received final approvals from the US Food & Drug Administration (USFDA) to manufacture and market Clopidogrel Tablets USP 75mg, which is being launched. Clopidogrel Tablets USP ...

Golden State Medical Supply, Inc. has voluntarily recalled 1 lot of Clopidogrel 75mg Tablets and 1 lot of Atenolol 25mg Tablets due to a report stating that a bottle containing Clopidogrel 75mg ...

International Laboratories, LLC is notifying distributors and customers by letter and is arranging for return of all recalled products. International Laboratories announced a voluntary recall of 1 lot ...

Feb. 21, 2006 -- The US Food and Drug Administration (FDA) has approved first-time generic formulations of cyclobenzaprine HCl 5-mg tablets for adjunctive use in the short-term treatment of muscle ...

Plavix Clopidogrel buy plavix 75 mg advisable to prevent blood clots after a recent heart attack or allergy. It is also important by patients with certain disorders of the incidence or blood vessels.

Golden State Medical Supply, Incorporated (GSMS, Inc.) - Camarillo, CA has initiated a voluntary recall of the products listed in the table below because a report was received that a bottle containing ...

Bridgewater/Princeton, NJ-The US FDA has approved a new 300-mg tablet of clopidogrel (Plavix, Sanofi-Aventis/Bristol-Myers Squibb) for use as a loading dose in acute ...

Diminished antiplatelet effect in patients with two loss-of-function alleles of the CYP2C19 gene. Increased risk of bleeding. Premature discontinuation increases risk of cardiovascular events; if ...

Sanofi-aventis and Bristol-Myers Squibb Company announced today that the US Food and Drug Administration (FDA) has approved a supplemental new drug application (sNDA) for a 300mg tablet of the ...